Intriguingly, despite the expressions of BID, CDKN3, and PLK1 being consistently higher in the renal carcinoma cell lines than in the normal renal cells across both the primary and tenth passages, shifts in the gene expression levels among the carcinoma lines were noted. This evidence concerns the gene BID and carcinoma.